Praveg Limited monitoring report: ₹143.94 crore used

What the latest disclosure is about

Praveg Limited has filed a final monitoring agency report covering the quarter ended December 31, 2025, prepared by CRISIL Ratings Limited. The report relates to the company’s preferential issue of equity shares and warrants that were allotted on May 17, 2024. The filing is made under SEBI’s monitoring framework, which requires an independent agency to track the use of issue proceeds against stated objectives.

The key takeaway is that the preferential issue raised less than originally planned, but CRISIL confirmed that the revised proceeds were fully utilised. The report also flags an “unfavorable event” related to forfeiture of warrant subscription amounts, which CRISIL said affected the viability of the stated objects of the issue.

Preferential issue size cut after under-subscription

According to the disclosure, Praveg’s initial plan was to raise ₹210.10 crore via the preferential route. The eventual realised proceeds were ₹143.94 crore, a drop of a little over 32% from the original target, due to under-subscription in equity and non-conversion of warrants.

The company’s documents also lay out the split between equity and warrants in both the original plan and the final proceeds. While the original structure assumed full warrant conversion, the final proceeds reflect the lower actual inflow during the monitoring period.

CRISIL confirms full deployment by January 14, 2026

CRISIL’s final report stated that the entire revised amount of ₹143.94 crore was deployed by January 14, 2026. The disclosure adds that both the preferential issue account and the monitoring agency account stood at nil balance as of that date.

The report is described as the final assessment because all proceeds have been fully utilised. CRISIL also confirmed that no deviations were observed from the stated objectives of the issue, based on the monitoring framework under the SEBI ICDR Regulations and the Monitoring Agency Agreement dated April 08, 2024.

How the company used the money: objects of the issue

The utilisation was primarily towards project expansion and development. Under the revised plan, project expansion and development was allocated ₹128.77 crore, reduced from the earlier stated ₹170.10 crore.

Loan or investment in subsidiaries saw the sharpest cut, down to ₹0.17 crore from ₹25.00 crore. General corporate purposes remained unchanged at ₹15.00 crore.

The disclosure also mentions a small unutilised balance of ₹0.01 crore (₹6.62 lakh) from the subsidiary allocation that was used for director expense reimbursement in a subsidiary, while the overall utilisation status was still stated as complete.

“Unfavorable event” flagged: warrant subscription forfeiture

A notable element in the monitoring agency report is CRISIL’s reference to an “unfavorable event.” This relates to forfeiture of warrant subscription amounts, which CRISIL said impacted the viability of the objects of the issue.

The disclosure does not provide additional detail on the counterparties or the operational consequences beyond this observation. It does, however, place the forfeiture in the context of the issue raising less than planned because of warrant non-conversion.

Preferential issue structure: shares, warrants, and pricing

The company’s approvals and notices outlined a preferential issue at an issue price of ₹955 per equity share and ₹955 per warrant. The shareholder notice for the Extraordinary General Meeting (EGM) scheduled on April 30, 2024, included the proposal to issue up to 13,43,024 equity shares and 8,56,976 warrants.

The warrant terms stated that the holder would pay 25% upfront and the balance 75% (₹716.25 per warrant) at the time of exercising the conversion right. The disclosure also notes that the “Relevant Date” for floor price determination was March 28, 2024.

Corporate approvals and key dates in the lead-up

Praveg’s filings include earlier board process references. The company said that its Board meeting held on June 28, 2023 approved, among other items, issuance of up to 7,75,000 equity shares and 8,75,000 convertible warrants to proposed allottees on a preferential basis, subject to approvals.

Other referenced documents include a PCS certificate for preferential issue of warrants dated June 30, 2023, and the allotment reference for equity shares and warrants on May 17, 2024. Separately, the documents also mention the approval of an employee stock option plan (ESOP Plan 2024), including extension of benefits to group companies.

Stock price context mentioned in the material

The text includes two market price references. One line shows “15:54 | 14-10-2025 339.00”, which appears to be a timestamped price reference. It also states, “The current price of Praveg Ltd is ₹271.10.” The filing itself is focused on monitoring and utilisation rather than price performance, but these figures provide context on the market price cited alongside the corporate disclosures.

Key numbers from the monitoring report

Why the monitoring report matters for investors

Preferential issues and warrant-linked fundraising can change capital structure and influence how quickly projects are funded. In this case, the monitoring report matters because it confirms that the revised proceeds were utilised and that the monitored accounts had nil balances after deployment.

At the same time, the disclosure highlights a funding gap versus the original plan, alongside CRISIL’s “unfavorable event” remark about forfeiture of warrant subscription amounts and its impact on viability of stated objects. Investors tracking execution risk typically watch for these two dimensions together: whether the money was spent as stated, and whether the final amount was adequate for the originally communicated objectives.

What to watch next

The filing positions this as the final monitoring report because utilisation is complete. The next information points, based on the documents referenced in the material, would typically come from project progress updates, subsidiary-level disclosures (where relevant), and any future board or shareholder approvals that affect capital structure.

For readers following the company’s fundraising history, the key dates to keep in view are the May 17, 2024 allotment, the quarter ended December 31, 2025 monitoring coverage, and the January 14, 2026 confirmation of full utilisation.

Conclusion

Praveg Limited’s final monitoring agency report from CRISIL confirms full utilisation of ₹143.94 crore from its revised preferential issue proceeds by January 14, 2026. The disclosure also documents the reduction from the original ₹210.10 crore plan due to under-subscription and warrant non-conversion, and notes an “unfavorable event” linked to forfeiture of warrant subscription amounts. The company’s subsequent updates on project expansion and any subsidiary-related outcomes will be the key follow-through items after the completion of this monitoring cycle.